Insider Transactions in Q3 2017 at Crispr Therapeutics Ag (CRSP)
Insider Transaction List (Q3 2017)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 05
2017
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Direct |
55,447
+50.0%
|
-
|
Sep 05
2017
|
Bradley J Ph D Bolzon Director |
SELL
Other acquisition or disposition
|
Indirect |
2,614,157
-55.55%
|
-
|
Sep 05
2017
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Indirect |
311,052
+50.0%
|
-
|
Sep 05
2017
|
Thomas Woiwode Director |
BUY
Other acquisition or disposition
|
Direct |
9,918
+50.0%
|
-
|
Sep 05
2017
|
Thomas Woiwode Director |
SELL
Other acquisition or disposition
|
Indirect |
2,614,157
-55.55%
|
-
|
Sep 05
2017
|
Thomas Woiwode Director |
BUY
Other acquisition or disposition
|
Indirect |
311,052
+50.0%
|
-
|
Sep 05
2017
|
Versant Venture Capital Iv, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
2,614,157
-55.55%
|
-
|
Sep 05
2017
|
Versant Venture Capital Iv, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
311,052
+50.0%
|
-
|
Sep 05
2017
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
3,853
-0.33%
|
$77,060
$20.33 P/Share
|
Sep 05
2017
|
Rodger Novak President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,853
+0.33%
|
$3,853
$1.81 P/Share
|
Aug 31
2017
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
14,617
-1.26%
|
$292,340
$20.87 P/Share
|
Aug 30
2017
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,000
-3.61%
|
$80,000
$20.0 P/Share
|
Aug 30
2017
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
58,103
-4.76%
|
$1,162,060
$20.31 P/Share
|
Aug 30
2017
|
Rodger Novak President |
BUY
Exercise of conversion of derivative security
|
Direct |
5,722
+0.47%
|
$5,722
$1.81 P/Share
|
Aug 28
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
88,011
-4.32%
|
$1,672,209
$19.79 P/Share
|
Aug 28
2017
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
23,154
-17.27%
|
$463,080
$20.09 P/Share
|
Aug 28
2017
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
17,692
-1.44%
|
$353,840
$20.06 P/Share
|
Aug 28
2017
|
Rodger Novak President |
BUY
Exercise of conversion of derivative security
|
Direct |
17,692
+1.41%
|
$17,692
$1.81 P/Share
|
Aug 25
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
14,913
-0.73%
|
$283,347
$19.52 P/Share
|
Aug 24
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
7,868
-0.38%
|
$149,492
$19.23 P/Share
|
Aug 23
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
7,035
-0.34%
|
$126,630
$18.53 P/Share
|
Aug 22
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
10,954
-0.53%
|
$197,172
$18.53 P/Share
|
Aug 21
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
1,250
-0.06%
|
$22,500
$18.51 P/Share
|
Aug 18
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
1,900
-0.09%
|
$34,200
$18.53 P/Share
|
Aug 17
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
13,593
-0.65%
|
$244,674
$18.74 P/Share
|
Aug 16
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
20,548
-0.97%
|
$390,412
$19.27 P/Share
|
Aug 15
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
25,586
-1.19%
|
$486,134
$19.53 P/Share
|
Aug 14
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
29,983
-1.38%
|
$569,677
$19.64 P/Share
|
Aug 08
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
19,850
-0.9%
|
$357,300
$18.71 P/Share
|
Aug 08
2017
|
Tyler Dylan Hyde Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,313
-0.85%
|
$23,634
$18.6 P/Share
|
Aug 07
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
15,623
-0.7%
|
$281,214
$18.53 P/Share
|
Aug 07
2017
|
Tyler Dylan Hyde Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
13,210
-7.88%
|
$237,780
$18.56 P/Share
|
Aug 04
2017
|
Tyler Dylan Hyde Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
477
-0.28%
|
$8,586
$18.55 P/Share
|
Aug 04
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
3,068
-0.14%
|
$55,224
$18.5 P/Share
|
Aug 03
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
47,409
-2.08%
|
$805,953
$17.77 P/Share
|
Aug 01
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
264
-0.01%
|
$4,488
$17.5 P/Share
|
Jul 31
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
5,248
-0.23%
|
$89,216
$17.51 P/Share
|
Jul 28
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
400
-0.02%
|
$6,800
$17.65 P/Share
|
Jul 27
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
40,912
-1.76%
|
$695,504
$17.62 P/Share
|
Jul 26
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
23,744
-1.01%
|
$403,648
$17.63 P/Share
|
Jul 25
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
9,186
-0.39%
|
$156,162
$17.52 P/Share
|
Jul 14
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
36,230
-1.51%
|
$579,680
$16.82 P/Share
|
Jul 13
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
33,629
-1.39%
|
$538,064
$16.87 P/Share
|
Jul 12
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
17,872
-0.74%
|
$285,952
$16.6 P/Share
|
Jul 11
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
14,120
-0.58%
|
$225,920
$16.52 P/Share
|
Jul 05
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
4,254
-0.17%
|
$68,064
$16.26 P/Share
|